Skip to main content
. Author manuscript; available in PMC: 2018 Aug 7.
Published in final edited form as: Cancer. 2017 Feb 20;123(8):1453–1463. doi: 10.1002/cncr.30560

Figure 3.

Figure 3

Patterns of changes in prescription drug use for financial reasons are illustrated by the number of comorbid conditions among cancer survivors only (multivariable, ordered logistic regression stratified by age [18–64 vs ≥ 65 years]; National Health Interview Survey, 2011–2014). Blue areas represent the percentages of cancer survivors that had no change in prescription drug use; red areas, the percentages that had exactly 1 change in prescription drug use; green areas, the percentages that had at least 2 changes in prescription drug use.